OptimizeRx CEO, Will Febbo, Discusses the Company's Gains In 2021 | TD Ameritrade Network


OptimizeRx CEO, Will Febbo, joined Nicole Petallides from
The Watchlist on the TD Ameritrade Network to discuss drug prices and the company's gains in recent quarters.